| |
IL- 2 |
IFN-γ |
IL-4 |
IL-10 |
TNF-α |
| Treatment at IC-10 Concentration |
Reporter GFP |
mRNA exp. |
Reporter GFP |
mRNA exp. |
Reporter GFP |
mRNA exp. |
Reporter GFP |
mRNA exp. |
Reporter GFP |
mRNA exp. |
| PMA+ Ion |
5.35±0.498 |
62.22±3.98 |
4.05±0.47 |
67.66±15.36 |
3.75±0.44 |
2.85
±0.27 |
3.21±0.33 |
3.180±0.29 |
|
|
| P + I + CSA(10µg/ml) |
1.48±0.26 |
4.46±0.48 |
1.13±0.02 |
3.60±0.58 |
1.11±0.004 |
0.62±0.10 |
1.13±0.03 |
0.36±0.05 |
|
|
| P + I +FK506
(8 µg/ml) |
1.87±0.12 |
5.39±0.40 |
1.37±.021 |
3.4±2.8 |
1.38±0.01 |
0.259±0.002 |
1.33±0.084 |
0.57±0.005 |
|
|
| P + I +Pentoxifylline (27.8µg/ml) |
4.77±0.57 |
63.7±6.63 |
3.791±0.59 |
63.82±6.519 |
3.205±1.11 |
3.12±0.49 |
2.80±0.54 |
4.41±0.685 |
|
|
| P + I +Chlorpyriphos (10µg/ml) |
2.16±0.21 |
9.27±0.424 |
1.49±0.12 |
6.79±3.88 |
1.38±0.21 |
0.268±0.01 |
1.54±0.413 |
0.622±0.04 |
|
|
| P + I + Cypermethin (10µg/ml) |
3.00±0.26 |
41.87±5.38 |
12.19±0.22 |
37.24±11.92 |
2.08±0.38 |
1.42±0.278 |
1.240±0.169 |
0.857±0.160 |
|
|
| P + I + Captan (1µg/ml) |
3.49±0.28 |
43.7±5.69 |
2.54±0.26 |
45.8±2.69 |
2.52±0.54 |
1.44±0.28 |
2.11±0.05 |
2.9±0.28 |
|
|
| LPS |
|
|
|
|
|
|
|
|
4.87±0.51 |
77.81±10.65 |
| LPS + CSA (10µg/ml) |
|
|
|
|
|
|
|
|
4.86±0.36 |
69.37±29.51 |
| LPS + FK506
(8 µg/ml) |
|
|
|
|
|
|
|
|
4.710±0.25 |
76.24±19.17 |
| LPS + Pentoxifilline (27.8µg/ml) |
|
|
|
|
|
|
|
|
2.01±0.24 |
30.51±3.58 |
| LPS +Chlorpyriphos (10µg/ml) |
|
|
|
|
|
|
|
|
4.85±0.8 |
79.96±12.65 |
| LPS + Cypermethrin (10µg/ml) |
|
|
|
|
|
|
|
|
4.9±0.32 |
80.94±7.9 |
| LPS + Captan (1µg/ml) |
|
|
|
|
|
|
|
|
5.27±0.7 |
82.28±5.57 |
